EMMA WAGNER: Open Payments
NPI 1851074959 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,376 in 96 payments from 14 companies in 2025. Trend: 2023 $68 · 2024 $761 · 2025 $1,376
Food & beverage: $1,377
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 46 | $463 |
| Xeris Pharmaceuticals, Inc. | 14 | $263 |
| ABBVIE INC. | 11 | $145 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $76 |
| Antares Pharma, Inc. | 1 | $75 |
| Esperion Therapeutics, Inc. | 4 | $71 |
| Novo Nordisk Inc | 3 | $51 |
| IBSA Pharma Inc. | 3 | $51 |
| Aimmune Therapeutics, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $41 |
Products named: Korlym, RECORLEV, VRAYLAR, ISTURISA, XYOSTED, NEXLETOL, Wegovy, Tirosint.
Industry payments across MO — which companies pay providers there.
